| 摘要 |
<p>It is intended to provide novel preventives/remedies for diseases caused by the growth of vascular smooth muscle, for example, re-occlusion occurring after a ballon-dilation treatment for cardiac coronary occlusion. Namely, vascular smooth muscle growth inhibitors, cycline-dependent kinase complex expression enhancers, preventives/remedies for diseases caused by the growth of muscular smooth muscle, a method of treating these diseases, etc. with the use of, as the active ingredient, 14-membered ring macrolide compounds such as erythromycin, its derivative, roxithromycin or its derivative.</p> |
